litlas
Log inCreate account

Stefano Romeo

Active 1998–2026

136
Papers
20,305
Citations
73
h-index
127
i10-index

Citations

Citations per year for Stefano Romeo1972: 1 citations1991: 1 citations1994: 1 citations1995: 3 citations1999: 7 citations2000: 10 citations2001: 18 citations2002: 20 citations2003: 20 citations2004: 34 citations2005: 31 citations2006: 22 citations2007: 32 citations2008: 54 citations2009: 77 citations2010: 109 citations2011: 103 citations2012: 106 citations2013: 161 citations2014: 147 citations2015: 245 citations2016: 248 citations2017: 218 citations2018: 214 citations2019: 730 citations2020: 1,118 citations2021: 1,149 citations2022: 973 citations2023: 800 citations2024: 1,277 citations2025: 803 citations2026: 43 citations1973–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1996–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,906 citing papers, 19.6% of this breakdownChina: 943 citing papers, 9.7% of this breakdownItaly: 882 citing papers, 9.1% of this breakdownUnited Kingdom: 699 citing papers, 7.2% of this breakdownGermany: 491 citing papers, 5.1% of this breakdownSweden: 353 citing papers, 3.6% of this breakdownJapan: 262 citing papers, 2.7% of this breakdownSpain: 256 citing papers, 2.6% of this breakdownAustralia: 254 citing papers, 2.6% of this breakdownFrance: 250 citing papers, 2.6% of this breakdownCanada: 224 citing papers, 2.3% of this breakdownNetherlands: 200 citing papers, 2.1% of this breakdown
0%19.6%Other 30.8%

Institutions

Fields

  • Medicine77.6%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Neuroscience4%
  • Immunology and Microbiology0.9%
  • Engineering0.5%
  • Nursing0.5%
  • Other2.6%

Topics

  • Liver Disease Diagnosis and Treatment18.9%
  • Diet, Metabolism, and Disease6.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.8%
  • Diet and metabolism studies3%
  • Alcohol Consumption and Health Effects2.9%
  • Lipid metabolism and disorders2.8%
  • Other60.8%

Coauthors

All papers

Open in search
  1. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

    Authors: Stefano Romeo, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox, L Pennacchio, Eric Boerwinkle, Jonathan C. Cohen, Helen H. Hobbs - Nature Genetics 2008 cited by 3,385

  2. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study

    Authors: Kausik K. Ray, Bart Molemans, W. Marieke Schoonen, Periklis Giovas, Sarah Bray, Gaia Kiru, Jennifer Murphy, Maciej Banach, Stefano De Servi, Dan Gaiță, Ioanna Gouni‐Berthold, G. Kees Hovingh, Jacek Jerzy Jozwiak, J. Wouter Jukema, Róbert Gábor Kiss, Serge Kownator, Helle K. Iversen, Vincent Maher, L. Masana, Alexander Parkhomenko, André Peeters, Piers Clifford, Katarı́na Rašlová, Peter Siostrzonek, Stefano Romeo, Dimitrios Tousoulis, Charalambos Vlachopoulos, Michal Vrablı́k, Alberico L. Catapano, Neil R Poulter, the DA VINCI study - European Journal of Preventive Cardiology 2020 cited by 767

  3. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance

    Authors: Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, Michael Charlton - Journal of Hepatology 2023 cited by 227

  4. Genetics and epigenetics of NAFLD and NASH: Clinical impact

    Authors: Mohammed Eslam, Luca Valenti, Stefano Romeo - Journal of Hepatology 2017 cited by 991

  5. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

    Authors: Cristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, Guido Baselli, Paola Dongiovanni, Irene Zanoni, Luigi Santoro, S. Maier, Antonio Liguori, Marica Meroni, V. Borroni, Roberta D’Ambrosio, Rocco Spagnuolo, Anna Alisi, Alessandro Federico, Elisabetta Bugianesi, Salvatore Petta, Luca Miele, Umberto Vespasiani‐Gentilucci, Quentin M. Anstee, Felix Stickel, Jochen Hampe, Janett Fischer, Thomas Berg, Anna Ludovica Fracanzani, Giorgio Soardo, Helen L. Reeves, Daniele Prati, Stefano Romeo, Luca Valenti - Journal of Hepatology 2020 cited by 362

  6. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans

    Authors: Adil Mardinoğlu, Hao Wu, Elias Björnson, Cheng Zhang, Antti Hakkarainen, Sari Räsänen, Sunjae Lee, Rosellina Margherita Mancina, Mattias Bergentall, Kirsi H. Pietiläinen, Sanni Söderlund, Niina Matikainen, Marcus Ståhlman, Per‐Olof Bergh, Martin Adiels, Brian Piening, Marit Granér, Nina Lundbom, Kevin Jon Williams, Stefano Romeo, Jens Nielsen, M Snyder, Mathias Uhlén, Göran Bergström, Rosie Perkins, Hanns–Ulrich Marschall, Fredrik Bäckhed, Marja‐Riitta Taskinen, Jan Borén - Cell Metabolism 2018 cited by 477

  7. The first MASH drug therapy on the horizon: Current perspectives of resmetirom

    Authors: Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B. Pajvani, Ming‐Hua Zheng, Alessio Aghemo, Luca Valenti - Liver International 2024 cited by 151

  8. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

    Authors: Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil A. Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, EPIDEMIC Study Investigators, Luisa Ronzoni, Cristiana Bianco, Laura Cerami, Veronica Torcianti, Giulia Periti, Sara Margarita, Rossana Carpani, Francesco Malvestiti, Ilaria Marini, Melissa Tomasi, Angela Lombardi, Jessica Rondena, Marco Maggioni, Roberta D’Ambrosio, Valentina Vaira, Anna Ludovica Fracanzani, Chiara Rosso, Grazia Pennisi, Salvatore Petta, Antonio Liguori, Luca Miele, Federica Tavaglione, Umberto Vespasiani‐Gentilucci, Marcello Dallio, Alessandro Federico, Giorgio Soardo, Jussi Pihlajamäki, Ville Männistö, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Valenti - Nature Medicine 2023 cited by 131

  9. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

    Authors: Rosellina Margherita Mancina, Paola Dongiovanni, Salvatore Petta, Piero Pingitore, Marica Meroni, Raffaela Rametta, Jan Borén, Tiziana Montalcini, Arturo Pujia, Olov Wiklund, George Hindy, Rocco Spagnuolo, Benedetta Maria Motta, Rosaria Maria Pipitone, Antonio Craxı̀, Silvia Fargion, Valério Nobili, Pirjo Käkelä, Vesa Kärjä, Ville Männistö, Jussi Pihlajamäki, Dermot F. Reilly, José Castro‐Perez, Julia Kozlitina, Luca Valenti, Stefano Romeo - Gastroenterology 2016 cited by 664

  10. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

    Authors: Paola Dongiovanni, Stefan Stender, Alessandro Pietrelli, Rosellina Margherita Mancina, Annalisa Cespiati, Salvatore Petta, Serena Pelusi, Piero Pingitore, Sara Badiali, Marco Maggioni, Ville Männistö, Stefania Grimaudo, Rosaria Maria Pipitone, Jussi Pihlajamäki, Antonio Craxı̀, Magdalena Taube, Lena Carlsson, Silvia Fargion, Stefano Romeo, Julia Kozlitina, Luca Valenti - Journal of Internal Medicine 2017 cited by 368

  11. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    Authors: Olivier Govaere, Sine Kragh Petersen, Nuria Martínez-López, Jasper Wouters, Matthias Van Haele, Rosellina Margherita Mancina, Oveis Jamialahmadi, Orsolya Bilkei‐Gorzo, Pierre Bel Lassen, Rebecca Darlay, Julien Peltier, Jeremy M. Palmer, Ramy Younes, Dina Tiniakos, Guruprasad P. Aithal, Michael Allison, Michèle Vacca, Melker Göransson, Rolando Berlinguer‐Palmini, James Clark, Michael Drinnan, Hannele Yki‐Järvinen, Jean‐François Dufour, Mattias Ekstedt, Sven Francque, Salvatore Petta, Elisabetta Bugianesi, Jörn M. Schattenberg, Christopher P. Day, Heather J. Cordell, Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 cited by 160

  12. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    Authors: Paola Dongiovanni, Salvatore Petta, Cristina Maglio, Anna Ludovica Fracanzani, Rosaria Maria Pipitone, Enrico Mozzi, Benedetta Maria Motta, Dorota Kamińska, Raffaela Rametta, Stefania Grimaudo, Serena Pelusi, Tiziana Montalcini, Anna Alisi, Marco Maggioni, Vesa Kärjä, Jan Borén, Pirjo Käkelä, V. Di Marco, Chao Xing, Valério Nobili, Bruno Dallapiccola, Antonio Craxı̀, Jussi Pihlajamäki, Silvia Fargion, Lars Sjöström, Lena Carlsson, Stefano Romeo, Luca Valenti - Hepatology 2014 cited by 529

  13. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease

    Authors: Stefano Romeo, Arun J. Sanyal, Luca Valenti - Cell Metabolism 2020 cited by 208

  14. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores

    Authors: Antonio De Vincentis, Federica Tavaglione, Oveis Jamialahmadi, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani‐Gentilucci - Clinical Gastroenterology and Hepatology 2021 cited by 144

  15. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease

    Authors: Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li‐Gao, Rosellina Margherita Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani‐Gentilucci, Frits R. Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Valenti, Stefano Romeo - Nature Medicine 2024 cited by 100

  16. Therapeutic opportunities for the treatment of NASH with genetically validated targets

    Authors: Daniel Lindén, Stefano Romeo - Journal of Hepatology 2023 cited by 84

  17. Statin use and non-alcoholic steatohepatitis in at risk individuals

    Authors: Paola Dongiovanni, Salvatore Petta, Ville Männistö, Rosellina Margherita Mancina, Rosaria Maria Pipitone, Vesa Kärjä, Marco Maggioni, Pirjo Käkelä, Olov Wiklund, Enrico Mozzi, Stefania Grimaudo, Dorota Kamińska, Raffaela Rametta, Antonio Craxı̀, Silvia Fargion, Valério Nobili, Stefano Romeo, Jussi Pihlajamäki, Luca Valenti - Journal of Hepatology 2015 cited by 383

  18. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

    Authors: Daniel Lindén, Andrea Ahnmark, Piero Pingitore, Ester Ciociola, Ingela Ahlstedt, Anne-Christine Andréasson, Kavitha Sasidharan, Katja Madeyski-Bengtson, Magdalena Zurek, Rosellina Margherita Mancina, Anna Lindblom, Mikael Bjursell, Gerhard Böttcher, Marcus Ståhlman, Mohammad Bohlooly‐Y, William G. Haynes, Björn Carlsson, Mark J. Graham, Richard Lee, Sue Murray, Luca Valenti, Sanjay Bhanot, Peter Åkerblad, Stefano Romeo - Molecular Metabolism 2019 cited by 210

  19. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

    Authors: Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, Guillaume Lassailly, Antonio De Vincentis, Umberto Vespasiani‐Gentilucci, S. U. Qadri, Robert Caïazzo, Hélène Verkindt, Chiara Saponaro, Julie Kerr‐Conte, Grégory Baud, Camille Marciniak, Mikaël Chetboun, Naima Oukhouya‐Daoud, Samuel Blanck, Jimmy Vandel, Lisa Olsson, Rima Chakaroun, Viviane Gnemmi, Emmanuelle Leteurtre, Philippe Lefèbvre, Joel T. Haas, Hannele Yki‐Järvinen, Sven Francque, Bart Staels, Carel W. le Roux, Valentina Tremaroli, Philippe Mathurin, Guillemette Marot, Stefano Romeo, François Pattou - Nature Medicine 2024 cited by 134

  20. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

    Authors: Federica Tavaglione, Oveis Jamialahmadi, Antonio De Vincentis, S. U. Qadri, Mohammad Erfan Mowlaei, Rosellina Margherita Mancina, Ester Ciociola, Simone Carotti, Giuseppe Perrone, Vincenzo Bruni, Ida Francesca Gallo, Dario Tuccinardi, Cristiana Bianco, Daniele Prati, Silvia Manfrini, Paolo Pozzilli, Antonio Picardi, Marco Caricato, Hannele Yki‐Järvinen, Luca Valenti, Umberto Vespasiani‐Gentilucci, Stefano Romeo - Clinical Gastroenterology and Hepatology 2022 cited by 110

  21. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease

    Authors: Oveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, Federica Tavaglione, Panu K. Luukkonen, Guido Baselli, Francesco Malvestiti, Dorothée Thuillier, Violeta Raverdy, Ville Männistö, Rosaria Maria Pipitone, Grazia Pennisi, Daniele Prati, Rocco Spagnuolo, Salvatore Petta, Jussi Pihlajamäki, François Pattou, Hannele Yki‐Järvinen, Luca Valenti, Stefano Romeo - Gastroenterology 2021 cited by 142

  22. Rare ATG7 genetic variants predispose patients to severe fatty liver disease

    Authors: Guido Baselli, Oveis Jamialahmadi, Serena Pelusi, Ester Ciociola, Francesco Malvestiti, Marco Saracino, Luigi Santoro, Alessandro Cherubini, Paola Dongiovanni, Marco Maggioni, Cristiana Bianco, Federica Tavaglione, Annalisa Cespiati, Rosellina Margherita Mancina, Roberta D’Ambrosio, Valentina Vaira, Salvatore Petta, Luca Miele, Umberto Vespasiani‐Gentilucci, Alessandro Federico, Jussi Pihlajamäki, Elisabetta Bugianesi, Anna Ludovica Fracanzani, Helen L. Reeves, Giorgio Soardo, Daniele Prati, Stefano Romeo, Luca Valenti, V. Borroni, Antonio Liguori, Luisa Ronzoni, Alessandro Cherubini, Luigi Santoro, Melissa Tomasi, Angela Lombardi, Mahnoosh Ostadreza, Elia Casirati, Ilaria Marini, S. Maier, Chiara Rosso, Gianluca Svegliati‐Baroni, Carlo Santaniello, Marcello Dallio - Journal of Hepatology 2022 cited by 93

  23. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

    Authors: Carlo Pirazzi, Luca Valenti, Benedetta Maria Motta, Piero Pingitore, Kristina Hedfalk, Rosellina Margherita Mancina, Maria Antonella Burza, Cesare Indiveri, Yvelise Ferro, Tiziana Montalcini, Cristina Maglio, Paola Dongiovanni, Silvia Fargion, Raffaela Rametta, Arturo Pujia, Linda Andersson, Saswati Ghosal, Malin Levin, Olov Wiklund, Michelina Iacovino, Jan Borén, Stefano Romeo - Human Molecular Genetics 2014 cited by 355

  24. Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis

    Authors: Ratika Sehgal, Mariana Ilha, Maija Vaittinen, Dorota Kamińska, Ville Männistö, Vesa Kärjä, Marjo Tuomainen, Kati Hanhineva, Stefano Romeo, Päivi Pajukanta, Jussi Pihlajamäki, Vanessa D. de Mello - Nutrients 2021 cited by 69